Early and repetitive novel-tracer PET-guided stereotactic body radiotherapy for nodal oligorecurrent prostate cancer after definitive first-line therapy
Modern-tracer PET/CT-based early and repetitive focal SBRT yields promising results with regard to bPFS, SBRT-FS, and ADT-FS with low toxicity. The ability of this approach to postpone initiation of palliative treatment with low toxicity should be re-evaluated prospectively.
Authors
- Daniel Zips (ORCID: https://orcid.org/0000-0001-5779-9675)
- Dirk Böhmer (ORCID: https://orcid.org/0000-0001-9285-6591)
- Goda Kalinauskaitė (ORCID: https://orcid.org/0000-0003-3798-1546)
- Holger Heidenreich
- Arne Grün (ORCID: https://orcid.org/0000-0002-3868-2719)
- Anne Kluge (ORCID: https://orcid.org/0000-0001-8628-0952)
- Selin Cumaoglu
- Kurt Miller
- Thorsten Schlomm
Institutions
- Humboldt-Universität zu Berlin (DE)
- Jüdisches Krankenhaus Berlin (DE)
- Bundeswehrkrankenhaus (DE)
- Sana Kliniken Leipziger Land (DE)
- Bundeswehrkrankenhaus Ulm (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Strahlentherapie und Onkologie
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1007/s00066-024-02304-9
- Citations
- 2
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.84
Funders
- Charité – Universitätsmedizin Berlin